Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae-Hoon Ko

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Immunity & Ageing : I & A|July 31, 2024
Overcoming the age-dependent SARS-CoV-2 vaccine response through hybrid immunity: analysis of humoral and cellular immunity with mass cytometry profilingZayakhuu Gerelkhuu, Sehee Park, Kyoung Hwa Lee, et al.
Journal of Medical Virology|December 23, 2023
Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variantsBeomki Lee, Jae-Hoon Ko, Yong Chan Kim, et al.
Microbiology Spectrum|October 17, 2022
Estimation of SARS-CoV-2 Neutralizing Activity and Protective Immunity in Different Vaccine Types Using Three Surrogate Virus Neutralization Test Assays and Two Semiquantitative Binding Assays Targeting the Receptor-Binding DomainBeomki Lee, Jae-Hoon Ko, Kyoung Hwa Lee, et al.
Frontiers in Cellular and Infection Microbiology|July 28, 2022
Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination SchedulesJu-Yeon Choi, Young Jae Lee, Jae-Hoon Ko, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 22, 2022
Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicitySeongman Bae, Jae-Hoon Ko, Ju-Yeon Choi, et al.
Immunity|December 18, 2020
PD-1-Expressing SARS-CoV-2-Specific CD8<sup>+</sup> T Cells Are Not Exhausted, but Functional in Patients with COVID-19Min-Seok Rha, Hye Won Jeong, Jae-Hoon Ko, et al.
Frontiers in Immunology|October 10, 2022
Kinetics of vaccine-induced neutralizing antibody titers and estimated protective immunity against wild-type SARS-CoV-2 and the Delta variant: A prospective nationwide cohort study comparing three COVID-19 vaccination protocols in South KoreaEliel Nham, Jae-Hoon Ko, Kyoung-Ho Song, et al.
Journal of Korean Medical Science|March 23, 2021
Clinical and Virologic Effectiveness of Remdesivir Treatment for Severe Coronavirus Disease 2019 (COVID-19) in Korea: a Nationwide Multicenter Retrospective Cohort StudyEun Jeong Joo, Jae Hoon Ko, Seong Eun Kim, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Immunity & Ageing : I & A|July 31, 2024
Overcoming the age-dependent SARS-CoV-2 vaccine response through hybrid immunity: analysis of humoral and cellular immunity with mass cytometry profilingZayakhuu Gerelkhuu, Sehee Park, Kyoung Hwa Lee, et al.
Journal of Medical Virology|December 23, 2023
Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variantsBeomki Lee, Jae-Hoon Ko, Yong Chan Kim, et al.
Microbiology Spectrum|October 17, 2022
Estimation of SARS-CoV-2 Neutralizing Activity and Protective Immunity in Different Vaccine Types Using Three Surrogate Virus Neutralization Test Assays and Two Semiquantitative Binding Assays Targeting the Receptor-Binding DomainBeomki Lee, Jae-Hoon Ko, Kyoung Hwa Lee, et al.
Frontiers in Cellular and Infection Microbiology|July 28, 2022
Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination SchedulesJu-Yeon Choi, Young Jae Lee, Jae-Hoon Ko, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 22, 2022
Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicitySeongman Bae, Jae-Hoon Ko, Ju-Yeon Choi, et al.
Immunity|December 18, 2020
PD-1-Expressing SARS-CoV-2-Specific CD8<sup>+</sup> T Cells Are Not Exhausted, but Functional in Patients with COVID-19Min-Seok Rha, Hye Won Jeong, Jae-Hoon Ko, et al.
Frontiers in Immunology|October 10, 2022
Kinetics of vaccine-induced neutralizing antibody titers and estimated protective immunity against wild-type SARS-CoV-2 and the Delta variant: A prospective nationwide cohort study comparing three COVID-19 vaccination protocols in South KoreaEliel Nham, Jae-Hoon Ko, Kyoung-Ho Song, et al.
Journal of Korean Medical Science|March 23, 2021
Clinical and Virologic Effectiveness of Remdesivir Treatment for Severe Coronavirus Disease 2019 (COVID-19) in Korea: a Nationwide Multicenter Retrospective Cohort StudyEun Jeong Joo, Jae Hoon Ko, Seong Eun Kim, et al.
Pageof 13